Exploring Neural, Muscle and Skeletal Organoids

Cristina Bombieri,Andrea Corsi,Elisabetta Trabetti,Alessandra Ruggiero,Giulia Marchetto,Gaetano Vattemi,Maria Teresa Valenti,Donato Zipeto,Maria Grazia Romanelli

DOI: https://doi.org/10.3390/ijms25021014

IF: 5.6

2024-01-14

International Journal of Molecular Sciences

Abstract:Organoids are self-organized, three-dimensional structures derived from stem cells that can mimic the structure and physiology of human organs. Patient-specific induced pluripotent stem cells (iPSCs) and 3D organoid model systems allow cells to be analyzed in a controlled environment to simulate the characteristics of a given disease by modeling the underlying pathophysiology. The recent development of 3D cell models has offered the scientific community an exceptionally valuable tool in the study of rare diseases, overcoming the limited availability of biological samples and the limitations of animal models. This review provides an overview of iPSC models and genetic engineering techniques used to develop organoids. In particular, some of the models applied to the study of rare neuronal, muscular and skeletal diseases are described. Furthermore, the limitations and potential of developing new therapeutic approaches are discussed.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

### What problem does this paper attempt to solve?

This paper aims to review the methods and applications of using induced pluripotent stem cells (iPSC) and three-dimensional (3D) organoid models to study rare diseases. Specifically:

1. **Technical Review**:
- Provide a technical overview of iPSC models, gene editing technologies, and 3D organoid culture methods.
- Explain how these technologies overcome the limitations of traditional 2D cell cultures and animal models.

2. **Organoid Models for Rare Neurological, Muscular, and Skeletal Diseases**:
- Describe specific organoid models used to study rare neurological, muscular, and skeletal diseases.
- Discuss the applications of these models in uncovering disease mechanisms, drug screening, and regenerative medicine.

3. **Applications of Gene Editing Technologies**:
- Introduce the latest technologies for genetic modification of iPSCs and organoids, particularly the CRISPR/Cas9 system.
- Demonstrate how these technologies are used to correct genetic defects and simulate specific disease states.

4. **Quality Control**:
- Emphasize the importance of rigorous quality control in organoid research to ensure data reliability and reproducibility.

Through the above content, the paper aims to showcase the potential and limitations of 3D organoid models as valuable tools in rare disease research and explore their prospects in precision medicine.